In: Journal of Infectious Diseases, ///-
|
In: Virus Evolution, 2018, vol. 4, no. 2, p. -
|
In: Rheumatology International, 2015, vol. 35, no. 2, p. 295-302
|
In: European Journal of Clinical Microbiology & Infectious Diseases, 2015, vol. 34, no. 3, p. 461-465
|
In: Vaccines, 2019, vol. 7, no. 4, p. 208
Highly attenuated poxviral vectors, such as modified vaccinia virus ankara (MVA), are promising vaccine candidates against several infectious diseases. One of the approaches developed to enhance the immunogenicity of poxvirus vectors is increasing the promoter strength and accelerating during infection production levels of heterologous antigens. Here, we have generated and characterized the ...
|
In: Plos pathogens, 2013, vol. 9, no. 11, p. e1003776
The mechanisms by which human immunodeficiency virus type 1 (HIV-1) crosses mucosal surfaces to establish infection are unknown. Acidic genital secretions of HIV-1-infected women contain HIV-1 likely coated by antibody. We found that the combination of acidic pH and Env- specific IgG, including that from cervicovaginal and seminal fluids of HIV-1-infected individuals, augmented transcytosis...
|
In: Journal of AIDS & clinical research, 2012, vol. S8:006, p. 1-10
Background: The development of a vaccine against HIV/AIDS capable of preventing virus infection has been hampered by the HIV envelope (Env) heterogeneity that makes it difficult to induce neutralizing antibodies against Env proteins from different HIV clades. Several studies have indicated that gp120 Env protein sequence tends to change considerably during the course of HIV disease which...
|
In: Plos one, 2011, vol. 6, no. 3, p. e18207
Neutralizing antibodies have been shown to protect macaques against SHIV challenge. However, genetically diverse HIV-1 clades have evolved, and a key question left unanswered is whether neutralizing antibodies can confer cross-clade protection in vivo. The novel human monoclonal antibody HGN194 was isolated from an individual infected with an HIV-1 clade AG recombinant circulating recombinant...
|
In: Journal of Molecular Medicine, 2014, vol. 92, no. 7, p. 757-767
|
Mémoire de bachelor : Haute école de santé Genève, 2018.
Introduction : Des progrès énormes ont été réalisés en matière de prévention de la transmission mère-enfant (TME) du VIH grâce à la mise en place de différents programmes en Afrique. En 2016, le taux de TME restait toutefois élevé en Afrique de l’Est. Objectif : Effectuer une revue de littérature pour déterminer quels facteurs influencent l'adhérence et l'accès aux traitements...
|